Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of diosmin for lower extremity telangiectasias and cellulite
2013-004539-57Phase 3Completed
- Sponsor
- Alio
- Start
- Dec 2013
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diosmin in telangiectasia and cellulite (3 arms), sponsored by Alio. Primary endpoint: Mean photonumeric cellulite severity score at treatment endpoint. Started Dec 2013; status: completed.
02
Drugs
diosmin
03
Conditions
telangiectasiacellulite
Beyond the preview
Go deeper on 2013-004539-57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004539-57.